Merck & Co Inc. reported an 11 percent drop in sales during the second quarter as increased generic competition pummeled sales of asthma and allergy drug Singulair.The Hunterdon County drugmaker today ...

A new study on a drug widely prescribed for asthma is binding itself to receptors in the brain and is linked to severe mental health issues and suicide, according to new research. The Food and Drug ...

The U.S. Food and Drug Administration today approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms ...

The Food and Drug Administration is warning consumers about a recall of the generic version of Singulair. Camber Pharmaceuticals is recalling one lot of Montelukast Sodium Tablets. They are the ...

Government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to serious mental health problems for some patients, according to a scientific ...

The U.S. Food and Drug Administration on Friday said it granted 10 drugmakers marketing approvals for the first generic forms of Singulair, the $5 billion-a-year asthma and allergy drug that is Merck ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. KANSAS CITY, Mo. — A blockbuster drug for ...

Montelukast (as sodium) 4mg; per packet. Take granules by mouth within 15mins of opening packet; may dissolve in 5mL of cold or room temperature baby formula or breast milk, or mix in spoonful of soft ...

Asthma and allergy drug montelukast -- sold as a generic and under the brand name Singulair -- will get a "boxed warning" over potential ties to neuropsychiatric effects, the U.S. Food and Drug ...

If you or someone you know is struggling with suicidal thoughts, you can call the U.S. National Suicide Prevention Lifeline at 988 any time day or night, or chat online. A new study on a drug widely ...

August 3, 2012 — The US Food and Drug Administration (FDA) today approved the first generic versions of the asthma and allergy drug montelukast sodium (Singulair, Merck), which will be marketed by 10 ...